Triptolide also reduced tube formation of human umbilical vein endothelial cells and angiogenesis through inhibiting the ERK1/2-HIF1-α-VEGFA axis [196]; triptolide decreased VEGFA, cluster of differentiation (CD) 31 in MDA-MB-231 tumor. This evidence concerns the gene HIF1A and neoplasm.